Health

Satellite Bio

Private Company

Satellite Bio is on a quest to create a better way to take on some of humankind’s most elusive diseases. It’s an audacious journey, and it’s led us to an entirely new category of regenerative medicine: Tissue Therapeutics. Tissue Therapeutics represents a revolutionary approach to using bioengineered tissues to assist organs affected by disease, and it lies at the heart of a future pipeline of cell-based treatments designed to tackle a broad range of severe, life-threatening conditions.

satellite.bio

U.S.

Therapeutics

Leaders
Dave Lennon, PhD

CEO

Christopher Chen, MD, PhD

Co-Founder

Sangeeta Bhatia, MD, PhD

Co-Founder

Arnav Chhabra, PhD

Co-Founder, Head of Platform R&D

Lightspeed Team
Dr. Ling Wong

Senior Advisor

Satellite Bio is on a quest to create a better way to take on some of humankind’s most elusive diseases. It’s an audacious journey, and it’s led us to an entirely new category of regenerative medicine: Tissue Therapeutics. Tissue Therapeutics represents a revolutionary approach to using bioengineered tissues to assist organs affected by disease, and it lies at the heart of a future pipeline of cell-based treatments designed to tackle a broad range of severe, life-threatening conditions.